HIPRAGUMBORO-G97
HIPRAGUMBORO-G97
Authorised
- Infectious bursal disease virus, strain GM97, Live
Product identification
Medicine name:
HIPRAGUMBORO-G97
HIPRAGUMBORO GM97 liofilizāts iekšķīgi lietojamas suspensijas pagatavošanai vistām
Active substance:
- Infectious bursal disease virus, strain GM97, Live
Target species:
-
Chicken (broiler)
-
Chicken (one day-old chick)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain GM97, Live100.00/50% Embryo Infective Dose1.00unit(s)
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Oral use
-
Chicken (broiler)
-
All relevant tissues0day
-
-
Chicken (one day-old chick)
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra, S.A.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/MRP/18/0034
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0352/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Czechia
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 18/12/2024
How useful was this page?:
